Riskpilot← Back to searchSign inGet full accessIKYA AS
ASActiveOrg 924484969Karenslyst allé 9, 0278 OsloOther education n.e.c. · NACE 8559Est. 20200 employeeswww.ikya.org
Revenue 2024
NOK 11M
+5% vs 2023
EBITDA margin
67.6%
+13% vs 2023
Equity ratio
6.9%
Financial strength
Net profit 2024
NOK 5,8M
+13% vs 2023
| Revenue | NOK 11M | +5% |
| EBITDA | NOK 7,5M | +13% |
| Net profit | NOK 5,8M | +13% |
| Total assets | NOK 12,6M | +24% |
| Equity | NOK 870K | +44% |
| Employees | 0 | — |
Legal name
IKYA AS
Org number
924484969
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
27. januar 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utdannelse, undervisning og salg av varer og tjenester, og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Karenslyst allé 9, 0278 Oslo
Website
www.ikya.org
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 414 | 8 055 | 6 855 | 10 563 | 11 042 |
| Staff expenses | −2 | −2 | −335 | −2 | −0 |
| EBITDA | 4 992 | 6 060 | 3 971 | 6 599 | 7 465 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 4 992 | 6 060 | 3 971 | 6 599 | 7 465 |
| Net financials | −9 | −6 | 5 | 8 | −7 |
| Profit before tax | 4 983 | 6 054 | 3 976 | 6 607 | 7 458 |
| Tax | 1 096 | 1 332 | 897 | 1 453 | 1 623 |
| Net profit | 3 887 | 4 721 | 3 079 | 5 154 | 5 835 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 019 | 7 219 | 7 308 | 10 167 | 12 589 |
| Equity | 1 074 | 792 | 926 | 605 | 870 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 945 | 6 427 | 6 383 | 9 562 | 11 719 |
| Total debt | 3 945 | 6 427 | 6 383 | 9 562 | 11 719 |
EBITDA margin
67.6%
This company
15.8%
Market median
+328% vs market
20202024
Equity ratio
6.9%
This company
38.2%
Market median
-82% vs market
20202024
Return on equity
670.7%
This company
18.4%
Market median
+3545% vs market
20202024
Net profit margin
52.8%
This company
8.1%
Market median
+552% vs market
20202024
Asset turnover
0.88×
This company
1.12×
Market median
+21% vs market
20202024
Debt / equity
13.47×
This company
0.62×
Market median
-2073% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
IKYA AS 
IKYA CLINIC ASBoard members of IKYA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Ikya | Chairman | 0 companies |
| Andrew Clayton Fritsch | Board of Directors | 0 companies |